HALO vs ISRG: fair value comparison
Halozyme Therapeutics, Inc. and Intuitive Surgical, Inc. · Updated 2026-08-31
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, HALO currently sits closer to the top of our discount ranking.
| HALO | ISRG | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $82.27 | $372.60 |
| 12-month range | $63.96–$82.27 | $353.33–$567.37 |
| Sector rank | #14 of 113 Healthcare | #19 of 113 Healthcare |
| Quality grade | A | A |
| Momentum grade | A | — |
| Leverage | High | — |
| Margin trend | Expanding | Stable |
| Revenue growth | High | Strong |
| RSI zone | Overbought | Neutral |
| 50/200-day trend | Mixed | — |
| DCF cross-check | Fairly Valued | — |
| 52-week position | The top quarter | The bottom quarter |
Full single-stock breakdowns: HALO fair value analysis · ISRG fair value analysis